52nd International Conference on Biomedical and Cancer Research (SciTech Biomed-Cancer 2024)

It gives me great pleasure to welcome to the “52nd International Conference on Biomedical and Cancer Research” which will be a hybrid conference held on the 22nd and 23rd of July 2024 at Hirosaki University Tokyo Office, Japan. The conference will cover session on Oncological Bioscience/Molecular Pathology, and Cancer Pathology. The conference will showcase research from multidisciplinary scientists. The virtual nature of the conference will enable a large group of researchers to participate, and a wider spectrum of the scientific community will be reached. I look forward to your participation at this exciting event.
Scientific Sessions

Advances in genomics and personalized medicine
Stem cell research and regenerative medicine
Bioinformatics and computational biology
Drug discovery and pharmacology
Biomaterials and tissue engineering
Respiratory diseases and pulmonary medicine
Endocrinology and hormone research
Reproductive health and fertility studies
Aging and gerontology research
Environmental health and toxicology
Biochemistry and molecular biology
Cell signaling and molecular pathways
Epigenetics and gene regulation
Imaging techniques in biomedical research
Cancer biology and oncology
Diabetes research and management
Precision medicine and biomarker discovery
Health disparities and social determinants of health
Public health policy and health economics
Clinical trials and regulatory affairs
Artificial intelligence in healthcare
Synthetic biology and genetic engineering
Environmental toxicology and pollution control
Oncogenes and tumor suppressor genes
Angiogenesis and cancer metastasis
Cancer immunotherapy
Targeted therapies in cancer treatment
Precision oncology
Biomarkers for cancer diagnosis and prognosis
Liquid biopsies for cancer detection
Epigenetics in cancer development
Role of inflammation in cancer
Cancer genomics and transcriptomics
Immunogenomics in cancer immunotherapy
Radiation therapy and its mechanisms of action
Chemotherapy and drug resistance in cancer
Radioimmunotherapy for cancer treatment
Immunomodulatory agents in cancer therapy
Cancer vaccines and their development
Liquid biopsy for monitoring treatment response
Circulating tumor cells and their significance
Computational modeling of cancer progression
Cancer disparities and healthcare access
Survivorship and quality of life in cancer patients
Palliative care and end-of-life issues
Cancer epidemiology and population studies
Environmental carcinogens and cancer prevention
Pediatric oncology and childhood cancer research
Geriatric oncology and cancer in the elderly
Rare cancers and orphan drug development
Artificial intelligence for early cancer detection
Patient-reported outcomes in cancer research
Cancer survivorship and long-term effects of treatment

Important Dates
Abstract Submission Opens02/01/2024
Abstract Submission Deadline09/07/2024
Abstract Submission Closes15/07/2024
Registration Opens02/01/2024
Registration Deadline07/07/2024
Registration Closes21/07/2024
Early bird registration20/05/2024
on spot registration22/07/2024
Date formats: d/m/y
Event Details
Leave a Comment

Event Details